![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 16, 2004.
Revised August 3, 2004.
Accepted for publication August 3, 2004.
The goal of this study was two-fold: i) to evaluate the biological effect of the novel pentacyclic acridine, 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) on human melanoma lines, possessing long telomeres, and ii) to elucidate the relationship between G-quadruplex-based telomerase inhibitor-induced cellular effects and telomere length/dysfunction. The cellular pharmacological effects of RHPS4 have been evaluated by treating melanoma lines with increasing concentrations of RHPS4. A dose-dependent inhibition of cell proliferation was observed in all the lines during short-term treatment. Flow cytometric analysis demonstrated that RHPS4 induced a dose-dependent accumulation of cells in the S-G2/M phase of cell cycle. The RHPS4-induced cell cycle alteration was irreversible even at low doses, and the cells died from apoptosis. At high RHPS4 concentration, apoptosis was accompanied by the induction of a senescence phenotype: large cell size, vacuolated cytoplasm and b-galactosidase activity. The short-term biological activity of RHPS4 was not due to telomere shortening, but it was associated with telomere dysfunction, in terms of presence of telomeric fusions, polynucleated cells, and typical images of telophase bridge. In conclusion, our results demonstrate that the G-quadruplex ligand RHPS4 can function in a telomere length-independent manner through its ability to cause telomere-capping alteration.
Key words:
Apoptosis, Mechanisms of cell killing/apoptosis
This article has been cited by other articles:
|
|
 |
|
  C. Leonetti, M. Scarsella, G. Riggio, A. Rizzo, E. Salvati, M. D'Incalci, L. Staszewsky, R. Frapolli, M. F. Stevens, A. Stoppacciaro, et al. G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors Clin. Cancer Res., November 15, 2008; 14(22): 7284 - 7291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pennarun, C. Granotier, F. Hoffschir, E. Mandine, D. Biard, L. R. Gauthier, and F. D. Boussin Role of ATM in the telomere response to the G-quadruplex ligand 360A Nucleic Acids Res., March 1, 2008; 36(5): 1741 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al. A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells Mol. Pharmacol., September 1, 2007; 72(3): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kelland Targeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway Clin. Cancer Res., September 1, 2007; 13(17): 4960 - 4963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis Eur. Respir. J., August 1, 2007; 30(2): 205 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Barbieri, A. R. Srinivasan, S. G. Rzuczek, J. E. Rice, E. J. LaVoie, and D. S. Pilch Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA Nucleic Acids Res., May 11, 2007; 35(10): 3272 - 3286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Qi, C.-P. Lin, X. Fu, L. M. Wood, A. A. Liu, Y.-C. Tsai, Y. Chen, C. M. Barbieri, D. S. Pilch, and L. F. Liu G-Quadruplexes Induce Apoptosis in Tumor Cells Cancer Res., December 15, 2006; 66(24): 11808 - 11816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Cookson, F. Dai, V. Smith, R. A. Heald, C. A. Laughton, M. F. G. Stevens, and A. M. Burger Pharmacodynamics of the G-Quadruplex-Stabilizing Telomerase Inhibitor 3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in Vitro: Activity in Human Tumor Cells Correlates with Telomere Length and Can Be Enhanced, or Antagonized, with Cytotoxic Agents Mol. Pharmacol., December 1, 2005; 68(6): 1551 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Todd, M. Johnston, and S. Neidle Highly prevalent putative quadruplex sequence motifs in human DNA Nucleic Acids Res., May 24, 2005; 33(9): 2901 - 2907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Burger, F. Dai, C. M. Schultes, A. P. Reszka, M. J. Moore, J. A. Double, and S. Neidle The G-Quadruplex-Interactive Molecule BRACO-19 Inhibits Tumor Growth, Consistent with Telomere Targeting and Interference with Telomerase Function Cancer Res., February 15, 2005; 65(4): 1489 - 1496. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
